NR1H4 and primary biliary cholangitis: FXR and FXR agonists can reduce oxidative stress, protect mitochondrial function and antagonize the SOD4-activated JNK signaling pathway.158-160 Obeticholic acid (OCA), an FXR agonist, is studied in patients with PBC that have an inadequate response to UDCA.